The impact of matched and mismatched donor–recipient genotypes for MDR1 polymorphisms ( G2677TA , C1236T and C3435T ) on the outcomes of patients after allogeneic haematopoietic stem cell transplantation
British Journal of Haematology · 2024
DOI: 10.1111/bjh.19588 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Ziwen Duan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, ATP Binding Cassette Transporter, Subfamily B, Genotype. Die Arbeit nennt 22 Literaturangaben.
Abstract (Originalsprache)
In this study, we investigated whether matched and mismatched multidrug resistance gene (MDR1) genotypes (G2677TA, C1236T and C3435T) were associated with prognosis in patients after allogeneic haematopoietic stem cell transplantation (allo‐HSCT). One hundred patients after transplantation and their donors were enrolled. Matched MDR1 G2677TA donor–recipient was associated with an increased risk of non‐relapse mortality (NRM) (29.5% vs. 6.2%, p = 0.002), poor overall survival (OS) (51.7% vs. 63.8%, p = 0.024) and disease‐free survival (DFS) (38.6% vs. 67%, p = 0.005). There were no differences in OS, DFS or NRM between MDR1 C1236T‐ and C3435T‐matched and ‐mismatched groups. Subgroup analysis suggested that within the matched MDR1 G2677TA group, male gender, haematopoietic cell transplantation‐specific comorbidity index ≥1, serum creatinine >137.2 μmol/L and post‐transplantation thrombocytopenia were associated with poor survival. Our results demonstrated that patients receiving matched MDR1 G2677TA allo‐HSCT experienced a poorer prognosis compared with the mismatched group. The potential mechanism may involve increased expression of P‐glycoprotein, leading to decreased accumulation of antimicrobial agents and ultimately contributing to the progression of inflammation. This identification of MDR1 G2677TA genotype compatibility holds promise as a valuable molecular tool for selecting donors for allo‐HSCT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China.
- Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou, China.
ORCID-Profile: Wei Xu, Kourong Miao
Zitieren
APA
Duan, Z., Zhang, X., Liu, Y., Wang, J., Zhu, H., Chen, R., Xu, W., & Miao, K. (2024). The impact of matched and mismatched donor–recipient genotypes for MDR1 polymorphisms ( G2677TA , C1236T and C3435T ) on the outcomes of patients after allogeneic haematopoietic stem cell transplantation. British Journal of Haematology. https://doi.org/10.1111/bjh.19588
Vancouver
Duan Z, Zhang X, Liu Y, Wang J, Zhu H, Chen R, et al. The impact of matched and mismatched donor–recipient genotypes for MDR1 polymorphisms ( G2677TA , C1236T and C3435T ) on the outcomes of patients after allogeneic haematopoietic stem cell transplantation. British Journal of Haematology. 2024. doi:10.1111/bjh.19588
BibTeX
@article{Duan2024,
author = {Duan, Ziwen and Zhang, Xiao and Liu, Yanping and Wang, Jiawen and Zhu, Han and Chen, Ruize and Xu, Wei and Miao, Kourong},
title = {The impact of matched and mismatched donor–recipient genotypes for MDR1 polymorphisms ( G2677TA , C1236T and C3435T ) on the outcomes of patients after allogeneic haematopoietic stem cell transplantation},
journal = {British Journal of Haematology},
year = {2024},
doi = {10.1111/bjh.19588}
}
EUVIMED